Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26, 6.
(2006). Dose response for infectivity of several strains of Campylobacter jejuni in chickens. Risk Analysis: An Official Publication of the Society for Risk Analysis. 26, 1613-1621.
(2006). Dose response for infectivity of several strains of ''Campylobacter jejuni'' in chickens. Risk Analysis. 1613-1621.
(2006). Dose response for infectivity of several strains of Campylobacter jejuni in chickens. Risk Analysis. 26, 1613–1621.
(2006). Dose response for infection by Escherichia coli O157:H7 from outbreak data. Risk Analysis: An Official Publication of the Society for Risk Analysis. 24, 401-407.
(2004). Dose response for infection by Escherichia coli O157:H7 from outbreak data. Risk Analysis: An Official Publication of the Society for Risk Analysis. 24, 401-407.
(2004). Development and Validation of Dose-Response Relationship for Listeria monocytogenes. Quantitative Microbiology. 1, 89-102.
(1999). Defective phagocytosis and clearance of Pseudomonas aeruginosa in the lung following bone marrow transplantation. The Journal of Immunology. 171, 4416–4424.
(2003). Defective Phagocytosis and Clearance of Pseudomonas aeruginosa in the Lung Following Bone Marrow Transplantation. The Journal of Immunology. 171(8), 4416 - 4424.
(2003). (2006). Cultural theory and risk: a review. Health, risk & society. 1, 71-90.
(1999). Cryptosporidium Hominis: Experimental Challenge of Healthy Adults. The American Journal of Tropical Medicine and Hygiene. 75, 5.
(2006). Cryptosporidium Hominis: Experimental Challenge of Healthy Adults. The American Journal of Tropical Medicine and Hygiene. 75, 5.
(2006). A comparison of Legionella pneumophila occurrence in hot water tanks and instantaneous devices in domestic, nosocomial, and community environments. Current Microbiology. 41, 374–376.
(2000). Cholera surveillance during the Haiti epidemic—the first 2 years. New England Journal of Medicine. 368, 599–609.
(2013). Cholera surveillance during the Haiti epidemic—the first 2 years. New England Journal of Medicine. 368, 599–609.
(2013). Campylobacter jejuni Strain CG8421: A Refined Model for the Study of Campylobacteriosis and Evaluation of Campylobacter Vaccines in Human Subjects. Clinical Infectious Diseases. 49, 10.
(2009). Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 49, 1512-1519.
(2009). Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects. Clinical infectious diseases. 49, 1512–1519.
(2009). Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.. Emerging infectious diseases. 7, 933.
(2001). Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.. Emerging infectious diseases. 7, 933.
(2001). Bioterrorism Related Inhalational Anthrax: The First 10 Cases Reported in the United States. Emerging Infectious Diseases. 7, 933-944.
(2001). Bioterrorism Related Inhalational Anthrax: The First 10 Cases Reported in the United States. Emerging Infectious Diseases. 7, 933-944.
(2001). Assessment of the risk of infection by Cryptosporidium or Giardia in drinking water from a surface water source. Water Research. 31, 1333–1346.
(1997). Assessment of the Duration of Protection in Campylobacter jejuni Experimental Infection in Humans. Infection and Immunity. 78, 4.
(2010).